SAC Re parent facing withdrawal threat
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Free Trial
  • Log in

SAC Re parent facing withdrawal threat

Investors in the pharmaceutical company Elan are suing Steven Cohen's SAC Capital Advisors, alleging that it engaged in illegal insider trading in Elan's options before clinical trial results were released.

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Gift this article